CAS Medical Systems Inc. (CASM)

2.44
NASDAQ : Health Technology
Prev Close 2.42
Day Low/High 2.42 / 2.45
52 Wk Low/High 1.06 / 2.70
Avg Volume 194.10K
Exchange NASDAQ
Shares Outstanding 29.34M
Market Cap 71.01M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Acquisition

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Acquisition

NEW YORK, March 5, 2019 /PRNewswire/ --  Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: CAS Medical Systems, Inc.

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Acquisition

INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Recently Announced Acquisition

NEW YORK, Feb. 26, 2019 /PRNewswire/ --  Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: CAS Medical Systems, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates CAS Medical Systems, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates CAS Medical Systems, Inc.

NEW YORK, Feb. 15, 2019 /PRNewswire/ --  WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of CAS Medical Systems, Inc.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of CAS Medical Systems, Inc.

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of CAS Medical Systems, Inc.

NEW YORK, Feb. 12, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against CAS Medical Systems, Inc.

Edwards Lifesciences Enters Into Agreement To Acquire CASMED

Edwards Lifesciences Enters Into Agreement To Acquire CASMED

IRVINE, Calif. and BRANFORD, Conn.

CASMED Reports Preliminary Net Sales For The 2017 Fourth Quarter

CASMED Reports Preliminary Net Sales For The 2017 Fourth Quarter

U.S. FORE-SIGHT cerebral oximetry sales up 18% for the quarter with record domestic monitor placements

CASMED Sells Non-invasive Blood Pressure Monitoring Product Line To SunTech Medical

CASMED Sells Non-invasive Blood Pressure Monitoring Product Line To SunTech Medical

Marks divestiture of final, non-core legacy assets and allows sole focus on FORE-SIGHT® tissue oximetry products

CASMED To Present At The ROTH Conference

CASMED Reports Preliminary Net Sales For The 2016 Fourth Quarter And Full Year

CASMED Reports Preliminary Net Sales For The 2016 Fourth Quarter And Full Year

FORE-SIGHT Cerebral Oximetry Sales up 17% for the Full Year

TheStreet Quant Rating: D (Sell)